Top Growth Trends in the Acute Respiratory Distress Syndrome (ARDS) Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Does the Projected Growth of the Acute Respiratory Distress Syndrome (ARDS) Market Compare Over the Forecast Period?
The market size for Acute Respiratory Distress Syndrome (ARDS) has experienced swift growth in the past few years. The market is predicted to expand from $1.29 billion in 2024 to $1.42 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. Factors such as advancements in critical care medicine, an aging population, the use of pulmonary rehabilitation, and multidisciplinary care teams have contributed to this growth during the historic period.
The market size for Acute Respiratory Distress Syndrome (ARDS) is anticipated to experience swift expansion in the coming years, with expectations of reaching a value of $2.17 billion by 2029, registering a CAGR of 11.1%. Factors contributing to the growth during the forecast period include international readiness in healthcare, advancements in vaccines and infectious disease control, telemedicine and remote patient monitoring, and a focus on patient-centric care models. Major emerging trends for the predicted period incorporate artificial lung technology, personalized respirator planning, lung-protective ventilation methods, and medication therapies for different ARDS subtypes.
What Key Drivers Are Accelerating the Growth of the acute respiratory distress syndrome (ards) Market During the Forecast Period?
The escalation in pneumonia cases is projected to fuel the expansion of the acute respiratory distress syndrome (ARDS) market. Pneumonia, an infection impacting one or both lungs, results in fluid or pus filling in the alveoli, the air sacs in the lungs. The resulting inflammatory response heightens the blood vessel permeability, causing fluid to leak into the alveoli. This fluid disrupts the oxygen and carbon dioxide exchange, leading to breathing discomfort. For instance, the Centre for Tropical Medicine and Global Health, a dominant healthcare research entity based in the UK, reported an elevated number of pneumonia cases in Kenya in November 2023, reaching 793,864 in 2022-2023, a substantial increase from 477,186 cases in 2020-2021. Consequently, the rising instances of pneumonia are catalysing the growth of the acute respiratory distress syndrome (ARDS) market.
Acute Respiratory Distress Syndrome (ARDS) Market Driver: A Surge in Respiratory Ailments Expected to Foster the Acute Respiratory Distress Syndrome (ARDS) Market
Request Your Free Acute Respiratory Distress Syndrome (ARDS) Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13005&type=smp
Who Are the Key Players Steering the Development of the Acute Respiratory Distress Syndrome (ARDS) Market?
Major companies operating in the acute respiratory distress syndrome (ards) market are:
• Johnson & Johnson Services Inc._x000D_
• Novartis AG_x000D_
• GlaxoSmithKline PLC_x000D_
• Medtronic PLC_x000D_
• Boehringer Ingelheim International GmbH_x000D_
How Are Consumer Trends Shaping the Current and Future Landscape of the Acute Respiratory Distress Syndrome (ARDS) Market?
Major firms in the acute respiratory distress syndrome (ARDS) market are concentrating on the creation of novel drugs and supplements, including Aviptadil, HSP90 inhibitors, and others, to maintain their market presence. Aviptadil is a formulated vasoactive intestinal peptide (VIP) that has a specific affinity to alveolar type II cells in the lungs. For instance, in November 2022, Zuventus Healthcare Ltd., a pharmaceutical industrial company based in India, initiated the release of Aviptadil to treat ARDS. Aviptadil – a vasoactive intestinal peptide supplement – enhances respiration and reduces mortality rates in patients with ARDS. This effect is brought about by Aviptadil’s capacity to safeguard and rejuvenate Type-2 Pneumocytes, rejuvenate Type-1 Pneumocytes, elevate surfactant synthesis, and inhibit IL-6 (interleukin 6) and tumor necrosis factor (TNF)-alpha.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Major Segments of the Acute Respiratory Distress Syndrome (ARDS) Market and Their Role in Driving Growth?
The acute respiratory distress syndrome (ARDS) market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes
3) By Severity: Mild, Moderate, Severe
4) By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users
Subsegments:
1) By Diagnosis: Imaging Tests, Blood Tests, Lung Function Tests, Other Diagnostic Methods
2) By Treatment: Mechanical Ventilation, Medications, Extracorporeal Membrane Oxygenation (ECMO), Supportive Care, Other Treatment Options
Which Geographical Regions Are Shaping the Acute Respiratory Distress Syndrome (ARDS) Market Growth?
North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2024. The regions covered in acute respiratory distress syndrome (ARDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Defining Aspects of the Acute Respiratory Distress Syndrome (ARDS) Market Landscape?
Acute respiratory distress syndrome (ARDS) is a potentially fatal illness characterized by non-compliant, or stiff lungs and low oxygenation. It is an acute, diffuse and inflammatory form of lung injury that can occur in seriously ill patients. Acute respiratory distress syndrome (ARDS) treatment involves mechanical ventilation with low tidal volumes and positive end-expiratory pressure (PEEP) to support oxygenation and prevent lung injury.
Browse Through More Similar Reports By The Business Research Company:
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2024
Respiratory Monitoring Devices Global Market Report 2024
Anesthesia And Respiratory Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: